By Sheeba M. | May 22, 2026
Curaleaf’s $26B Revenue Secret: Why Margins Still Tell a Different Story
Curaleaf Holdings stands alone as North America’s dominant cannabis multi-state operator (MSO)—a $26B revenue juggernaut with over 200 retail locations across 24 states. Yet its stock has plunged 26.08% this week, signaling investor exhaustion with a fundamental arithmetic problem: revenue doesn’t translate to earnings in the cannabis industry.
The Section 280E Trap
Internal Revenue Code Section 280E is the invisible tax bomb buried in every cannabis company’s financial statements. It prohibits cannabis businesses from deducting ordinary business expenses like rent, labor, marketing, and distribution. Only cost of goods sold (COGS) is deductible.
For Curaleaf, this creates a perverse economic dynamic: more revenue doesn’t scale profitably. Every dollar of wholesale or retail margin gets taxed as if the company has zero expenses. Result? Negative GAAP earnings despite positive EBITDA.
Peer Comparison: Why VROOF and AAWH Are Different
Verano Holdings (VROOF) and American Aurora Holdings (AAWH) are smaller but more profitable per capita because they’ve optimized for state-by-state compliance rather than pure scale. Curaleaf’s size became a liability in a Section 280E world.
Meanwhile, Canadian producers like Trulieve (TCNNF) operate under a different tax regime but face international oversupply issues and currency headwinds. OrganiGram (OGI) has begun cutting costs aggressively.
What’s the Exit?
For Curaleaf shareholders, the thesis depends on one critical assumption: federal legalization that eliminates or restructures Section 280E. Without that catalyst, CURLF remains a revenue story with structurally depressed margins.
Short-term traders are watching consolidation. Industry consolidation could reduce operator overhead per capita and create tax-advantaged structures. Longer-term, Curaleaf needs Washington to act—or its stock remains a value trap despite market-leading position.
Sources
- Internal Revenue Code § 280E — Federal prohibition on cannabis business expense deductions
- SEC EDGAR — Curaleaf 10-K filing — Full tax impact disclosure
- NORML Federal Reform Updates — Legislative status
Track cannabis stocks with the Weedstock Real-Time Tracker